Literature DB >> 21360536

TNM stage and grade in predicting the prognosis of operated, non-functioning neuroendocrine carcinoma of the pancreas--a single-institution experience.

Franz Sellner1, Sabine Thalhammer, Stefan Stättner, Josef Karner, Martin Klimpfinger.   

Abstract

OBJECTIVE: To evaluate the prognostic significance of TNM and grading categories in curatively resected non-functioning neuroendocrine pancreatic carcinoma (nfnepC).
METHOD: Eighteen nfnepC were retrospectively analyzed for differences in survival.
RESULTS: (1) There was a correlation between pT (P = 0.026), respectively pM categories (P = 0.016) and survival. (2) G categories and length of survival were closely correlated (P = 0.0036). (3) Disease stages I-IV had a significant effect on survival (P = 0.051). (4) The WHO classification in well and poorly differentiated carcinomas proved to be the most conclusive predictive factor (P = 0.0009). (5) Subgroups with significantly different prognoses determined by histological grade were present within disease stage II.
CONCLUSIONS: The retrospective analysis showed a good correlation between survival and pT, pM, tumor stage, G categories, and WHO classification in well and poorly differentiated carcinomas. Including histological differentiation in the staging system or carrying it out separately in well and poorly differentiated carcinomas, could enhance the predictive potential of TNM-based disease stages.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21360536     DOI: 10.1002/jso.21889

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

Review 1.  Contemporary management of nonfunctioning pancreatic neuroendocrine tumors.

Authors:  Rebecca M Minter; Diane M Simeone
Journal:  J Gastrointest Surg       Date:  2011-10-19       Impact factor: 3.452

2.  Extensive multiarterial resection attending total duodenopancreatectomy and adrenalectomy for MEN-1-associated neuroendocrine carcinomas.

Authors:  Vyacheslav Ivanovich Egorov; Alexander Felixovich Kharazov; Alla Ivanovna Pavlovskaya; Roman Valeryevich Petrov; Natalia Sergeevna Starostina; Eugeny Valerievich Kondratiev; Ekaterina Mikhailovna Filippova
Journal:  World J Gastrointest Surg       Date:  2012-10-27

3.  A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.

Authors:  Trevor A Ellison; Christopher L Wolfgang; Chanjuan Shi; John L Cameron; Peter Murakami; Liew Jun Mun; Aatur D Singhi; Toby C Cornish; Kelly Olino; Zina Meriden; Michael Choti; Luis A Diaz; Timothy M Pawlik; Richard D Schulick; Ralph H Hruban; Barish H Edil
Journal:  Ann Surg       Date:  2014-02       Impact factor: 12.969

4.  Clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors.

Authors:  Mariko Furukori; Koji Imai; Hidenori Karasaki; Kenji Watanabe; Kensuke Oikawa; Naoyuki Miyokawa; Masahiko Taniguchi; Hiroyuki Furukawa
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

5.  Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma.

Authors:  Jung Hoon Kim; Hyo Won Eun; Young Jae Kim; Jeong Min Lee; Joon Koo Han; Byung-Ihn Choi
Journal:  Eur Radiol       Date:  2015-08-08       Impact factor: 5.315

Review 6.  Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review.

Authors:  Emma Elizabeth Ilett; Seppo W Langer; Ingrid Holst Olsen; Birgitte Federspiel; Andreas Kjær; Ulrich Knigge
Journal:  Diagnostics (Basel)       Date:  2015-04-08

7.  Prognostic factors of non-functioning pancreatic neuroendocrine tumor revisited: The value of WHO 2010 classification.

Authors:  Jiyoung Bu; Sangmin Youn; Wooil Kwon; Kee Taek Jang; Sanghyup Han; Sunjong Han; Younghun You; Jin Seok Heo; Seong Ho Choi; Dong Wook Choi
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-02-26

8.  International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.

Authors:  Marcia Irene Canto; Femme Harinck; Ralph H Hruban; George Johan Offerhaus; Jan-Werner Poley; Ihab Kamel; Yung Nio; Richard S Schulick; Claudio Bassi; Irma Kluijt; Michael J Levy; Amitabh Chak; Paul Fockens; Michael Goggins; Marco Bruno
Journal:  Gut       Date:  2012-11-07       Impact factor: 23.059

Review 9.  Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review.

Authors:  Anneke P J Jilesen; Casper H J van Eijck; K H in't Hof; S van Dieren; Dirk J Gouma; Els J M Nieveen van Dijkum
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.